SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VICL (Vical Labs)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: William Strop who wrote (338)9/7/1997 7:46:00 PM
From: John McCarthy   of 1972
 
William -

If you get a chance, catch the article in this months
Discover about Vaccines. You'll be pleased.

In addition, and I am not trying to make you feel good, but ,
it really appears that VICAL's *approach* has far reaching
consequences - if they work it out.

One of the stocks I'm in is DEPO. In short, *all* they
do is wrap their product around an existing chemo agent - I forget which one - and then place it in the body.

*This is for use in HEAD AND NECK cancer* Get it?

Obviously, this is *NOT* a cure, and on *AVERAGE* all their product
does is keep people alive 90 days longer than if they had
not taken Depo's product.

Please understand, I am NOT deprecating this.

But I am trying to contrast it with VICAL - whose methodology is REALLY GOING AFTER THE BAD GUY BY HAVING
THE BODIES IMMUNE SYSTEM KILL THE CANCER.

If Vical's approach wins, we all win.

Regards,

John McCarthy

Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext